Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Jan 10, 2021 12:38pm
123 Views
Post# 32263331

RE:RE:RE:RE:RE:power

RE:RE:RE:RE:RE:powerInteresting to see the excitement back in 2016 just after the financing on June 9. Hoping tomorrow's presentation will foreshadow good things to come.

newdaydawning wrote: Great post Ciao! But you left out the biggest ace-in-the-hole: PGX. The current money raise - almost assuredly over-subscribed - is earmarked largely for PGX advancement, IMO. Demonstration of PGX at commercial scale - not a trivial matter - is critical to executing to deals with the trans-nationals that sense mega-opportunity. CZO has stated that PGX could be a standalone business.
The market seems to be confirming. GLTA longs.

Ciao wrote:
Stocker46 wrote: Amazing run in the 1st 3 days of this week ... up 70 cents or about 60%.
Will we see some profit taking tomorrow or are we headed for $2 plus?

It would be nice to see a jump to the main TSX exchange.
 


Regardless of how exciting the future for the company is, the fast runup will result in profit taking tomorrow. This will give an opportunity for new buyers to get in on the pull back.

From Q1 NR:

Gilles Gagnon, M.Sc., MBA, President and CEO of Ceapro, stated, “We are very pleased with ending the first quarter of 2016 with these exceptional results and aim to continue to drive value in our high-value de-risked base business in cosmeceuticals, which has shown to be a proven result of the effectiveness of our business strategy.”

“With these results combined with the recent announcement of the renewal of a long-term agreement with our major distributor, Symrise AG, Ceapro has established a solid base for year-over-year growth. Beyond these excellent financial results, we will continue to develop our pipeline and execute our projects rigorously toward market expansion into the profitable nutraceutical and pharmaceutical sectors as we anticipate top-line data from our beta glucan study and our avenanthramides bioavailability study, and our expected launch of Ceapro’s first two clinical studies this year with these two important value drivers.”

You can taste the excitement in his words.




<< Previous
Bullboard Posts
Next >>